Jeonbuk National University spin-off to accelerate drug development through AI transformation
Hops BioSciences, a startup spun off from Jeonbuk National University, has been selected for the Daonda Program, a global corporate collaboration initiative. The university said that through the program, the company will pursue an artificial intelligence (AI) transformation strategy aimed at integrating AI throughout the drug development process. The program is jointly operated by the Ministry of…
Hops BioSciences, a university spinoff from Jeonbuk National University, has been chosen for the Daonda Program, a global corporate partnership initiative. The program, co-managed by the Ministry of SMEs and Startups, Korea Institute of Startup and Entrepreneurship Development, and French software giant Dassault Systèmes, aims to boost Korean startups' technological prowess using Dassault Systèmes' technology, knowledge, and worldwide network.
Lee Jeong-hwan, Hops BioSciences' CEO and a professor at the university's Department of Biological Sciences, expressed his intention to undergo an AI transformation. He stated, "Our goal is to become an AI (AX) company by integrating AI technologies into every stage of drug development, thereby significantly cutting down development time and expenses."
The CEO further elaborated, "We intend to accelerate our expansion by leveraging the resources and expertise provided by the Daonda Program."
Written by urgent.news from The Korea Times's reporting — not their text. Machine-written — it may contain errors, so check the original before relying on it.
